Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-072848·BNB PLUS CORP.
Schedule 13G ownership disclosure
APPLIED DNA SCIENCES INC
Common Stock, $0.001 par value · CUSIP: 03815U409
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Anson Funds Management LP
Shares: 3,142,032 · Class: 5.4%
- Anson Management GP LLC
Shares: 3,142,032 · Class: 5.4%
- Tony Moore
Shares: 3,142,032 · Class: 5.4%
- Anson Advisors Inc.
Shares: 3,142,032 · Class: 5.4%
- Amin Nathoo
Shares: 3,142,032 · Class: 5.4%
- Moez Kassam
Shares: 3,142,032 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072848
- Form type
- SCHEDULE 13G/A
- Filer
- BNB PLUS CORP.
- CIK
- CIK 744452
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership